PDS Biotechnology Corp — Director's Dealing 2022

Jan 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2022-01-19

Reporting Person: CONN GREGORY (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-19	Employee Stock Option (Right to Buy)	$6.28	A	112100	Acquired	2032-01-19	Common Stock (112100)	Direct

Footnotes

F1: This option, representing a right to purchase a total of 112,100 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026.